Antengene To Present One Oral and Four Abstracts at ASCO 2024
/PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated...
Source: prnewswire.com
Page 2 - Hematologic Malignancies News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Hematologic Malignancies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Hematologic Malignancies Today - Breaking & Trending Today
ASCO 2024 | Ascentage Pharma Releases Latest Results from Multiple Clinical Studies of Its Lead Drug Candidates
/PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and...
Source: prnewswire.com
Innate Pharma : 5 abstracts concernant des candidats-médicaments d'Innate ont été sélectionnés pour le congrès annuel de l'ASCO
Innate Pharma SA annonce aujourd'hui que 5 abstracts concernant des candidats-médicaments d'Innate ont été sélectionnés pour le congrès annuel de...
Source: boursier.com
Inhibikase Therapeutics Reports First Quarter Financial Results and Highlights Recent Period Activity
Company to host conference call on Thursday, May 16, 2024 at 8:00 a.m. ETBOSTON and ATLANTA, May 15, 2024 -- Inhibikase Therapeutics, Inc. , a clinical-stage pharmaceutical company developing...
Source: marketscreener.com
Inhibikase Therapeutics Reports First Quarter Financial
Company to host conference call on Thursday, May 16, 2024 at 8:00 a.m. ET...
Source: globenewswire.com